Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
An antibody cocktail against SARS-CoV-2
Abstract
Acknowledgments
Supplementary Material
Summary
Resources
References and Notes
(0)eLetters
eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.
Log In to Submit a ResponseNo eLetters have been published for this article yet.
Information & Authors
Information
Published In
21 August 2020
Copyright
Article versions
Submission history
Acknowledgments
Authors
Funding Information
Metrics & Citations
Metrics
Article Usage
Altmetrics
Citations
Cite as
- Johanna Hansen et al.
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova, Vaccines, 11, 3, (637), (2023).https://doi.org/10.3390/vaccines11030637
- Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences, Medicina, 59, 3, (507), (2023).https://doi.org/10.3390/medicina59030507
- A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19), Antibodies, 12, 1, (5), (2023).https://doi.org/10.3390/antib12010005
- Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses, Frontiers in Virology, 3, (2023).https://doi.org/10.3389/fviro.2023.1128253
- Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies, Frontiers in Microbiology, 14, (2023).https://doi.org/10.3389/fmicb.2023.1122868
- Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro, Frontiers in Immunology, 14, (2023).https://doi.org/10.3389/fimmu.2023.1112505
- B cell receptor repertoire analysis from autopsy samples of COVID-19 patients, Frontiers in Immunology, 14, (2023).https://doi.org/10.3389/fimmu.2023.1034978
- Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape, Frontiers in Immunology, 13, (2023).https://doi.org/10.3389/fimmu.2022.1010105
- State of the art in epitope mapping and opportunities in COVID-19, Future Science OA, 9, 1, (2023).https://doi.org/10.2144/fsoa-2022-0048
- High-throughput saturation mutagenesis generates a high-affinity antibody against SARS-CoV-2 variants using protein surface display assay on a human cell, PLOS Pathogens, 19, 2, (e1011119), (2023).https://doi.org/10.1371/journal.ppat.1011119
- See more
View Options
View options
PDF format
Download this article as a PDF file
Download PDFCheck Access
Log in to view the full text
AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.
- Become a AAAS Member
- Activate your AAAS ID
- Purchase Access to Other Journals in the Science Family
- Account Help
More options
Register for free to read this article
As a service to the community, this article is available for free. Login or register for free to read this article.
Buy a single issue of Science for just $15 USD.